As of Jan 17
| +0.02 / +0.46%|
The 6 analysts offering 12-month price forecasts for Inovio Pharmaceuticals Inc have a median target of 11.50, with a high estimate of 14.00 and a low estimate of 10.00. The median estimate represents a +161.36% increase from the last price of 4.40.
The current consensus among 6 polled investment analysts is to Buy stock in Inovio Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.